Clin Endosc.  2015 May;48(3):209-215. 10.5946/ce.2015.48.3.209.

Recent Advances in Gastrointestinal Stent Development

Affiliations
  • 1Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea. ldh@inha.ac.kr
  • 2National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders (NCEED), Incheon, Korea.
  • 3Utah-Inha DDS & Advanced Therapeutics Research Center, Incheon, Korea.

Abstract

Endoscopic stenting is increasingly being used in the management of gastrointestinal luminal obstruction, and has become the current treatment of choice for the palliation of blockage caused by malignant or benign growths. A variety of stents have been developed to enhance the efficacy of the procedure, and improvements are ongoing. In this article, we review the history of, and recent advances in, gastrointestinal stenting. We describe the rationale behind the design as well as the resulting outcome for each stent type.

Keyword

Stents; Drug-eluting stents; Endoscopy, gastrointestinal

MeSH Terms

Drug-Eluting Stents
Endoscopy, Gastrointestinal
Phenobarbital
Stents*
Phenobarbital

Figure

  • Fig. 1 Fully covered self-expandable metal stent (ComVi Stent; Taewoong). Adapted from http://www.stent.net, with permission from Taewoong.24

  • Fig. 2 Fully covered self-expandable metal stent with anti-migratory flared ends. Adapted from http://www.stent.net, with permission from Taewoong.24

  • Fig. 3 Anti-reflux fully covered self-expandable metal stent with an anti-reflux valve at the distal end. Adapted from http://www.stent.net, with permission from Taewoong.24


Cited by  1 articles

Current Status of Biliary Metal Stents
Hyeong Seok Nam, Dae Hwan Kang
Clin Endosc. 2016;49(2):124-130.    doi: 10.5946/ce.2016.023.


Reference

1. Sabharwal T, Morales JP, Irani FG, Adam A. CIRSE: Cardiovascular and Interventional Radiological Society of Europe. Quality improvement guidelines for placement of esophageal stents. Cardiovasc Intervent Radiol. 2005; 28:284–288. PMID: 15886931.
Article
2. Siersema PD. Treatment options for esophageal strictures. Nat Clin Pract Gastroenterol Hepatol. 2008; 5:142–152. PMID: 18250638.
Article
3. ASGE Technology Committee. Varadarajulu S, Banerjee S, et al. Enteral stents. Gastrointest Endosc. 2011; 74:455–464. PMID: 21762904.
Article
4. Kochar R, Shah N. Enteral stents: from esophagus to colon. Gastrointest Endosc. 2013; 78:913–918. PMID: 24237947.
Article
5. McLoughlin MT, Byrne MF. Endoscopic stenting: where are we now and where can we go? World J Gastroenterol. 2008; 14:3798–3803. PMID: 18609702.
6. Guo Q, Guo S, Wang Z. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties. J Control Release. 2007; 118:318–324. PMID: 17289208.
Article
7. Tanaka T, Takahashi M, Nitta N, et al. Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion. 2006; 74:199–205. PMID: 17341853.
Article
8. Dormann AJ, Eisendrath P, Wigginghaus B, Huchzermeyer H, Devière J. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy. 2003; 35:207–211. PMID: 12584638.
Article
9. Schumacher B, Lubke H, Frieling T, Haussinger D, Niederau C. Palliative treatment of malignant esophageal stenosis: experience with plastic versus metal stents. Hepatogastroenterology. 1998; 45:755–760. PMID: 9684128.
10. Cusumano A, Ruol A, Segalin A, et al. Push-through intubation: effective palliation in 409 patients with cancer of the esophagus and cardia. Ann Thorac Surg. 1992; 53:1010–1014. PMID: 1375823.
Article
11. Fugger R, Niederle B, Jantsch H, Schiessel R, Schulz F. Endoscopic tube implantation for the palliation of malignant esophageal stenosis. Endoscopy. 1990; 22:101–104. PMID: 1694121.
Article
12. Castaño R, Lopes TL, Alvarez O, Calvo V, Luz LP, Artifon EL. Nitinol biliary stent versus surgery for palliation of distal malignant biliary obstruction. Surg Endosc. 2010; 24:2092–2098. PMID: 20174944.
Article
13. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med. 1993; 329:1302–1307. PMID: 7692297.
Article
14. Roseveare CD, Patel P, Simmonds N, Goggin PM, Kimble J, Shepherd HA. Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol. 1998; 10:653–657. PMID: 9744693.
15. Jaganmohan S, Lee JH. Self-expandable metal stents in malignant biliary obstruction. Expert Rev Gastroenterol Hepatol. 2012; 6:105–114. PMID: 22149586.
Article
16. Kim JH. Endoscopic stent placement in the palliation of malignant biliary obstruction. Clin Endosc. 2011; 44:76–86. PMID: 22741117.
Article
17. Song HY, Jung HY, Park SI, et al. Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. Radiology. 2000; 217:551–557. PMID: 11058659.
Article
18. Baerlocher MO, Asch MR, Dixon P, et al. Interdisciplinary Canadian guidelines on the use of metal stents in the gastrointestinal tract for oncological indications. Can Assoc Radiol J. 2008; 59:107–122. PMID: 18697717.
19. Siersema PD, Hop WC, van Blankenstein M, Dees J. The Rotterdam Esophageal Tumor Study Group. A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. Gastrointest Endosc. 2000; 51:139–145. PMID: 10650254.
Article
20. Kubba AK, Krasner N. An update in the palliative management of malignant dysphagia. Eur J Surg Oncol. 2000; 26:116–129. PMID: 10744928.
Article
21. van Boeckel PG, Siersema PD, Sturgess R, et al. A new partially covered metal stent for palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc. 2010; 72:1269–1273. PMID: 20951988.
Article
22. Bona D, Laface L, Bonavina L, et al. Covered nitinol stents for the treatment of esophageal strictures and leaks. World J Gastroenterol. 2010; 16:2260–2264. PMID: 20458763.
Article
23. Verschuur EM, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol. 2008; 103:304–312. PMID: 17900325.
Article
24. TaeWoong Medical. Taewoong Niti-S biliary stents [Internet]. Goyang: TaeWoong Medical;c2012. cited 2015 May 14. Available from: http://www.stent.net.
25. Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009; (4):CD005048. PMID: 19821338.
Article
26. Bartelsman JF, Bruno MJ, Jensema AJ, Haringsma J, Reeders JW, Tytgat GN. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc. 2000; 51:134–138. PMID: 10650253.
Article
27. Sabharwal T, Morales JP, Salter R, Adam A. Esophageal cancer: self-expanding metallic stents. Abdom Imaging. 2005; 30:456–464. PMID: 15688108.
Article
28. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003; 52:922–926. PMID: 12801944.
Article
29. Morgan R, Adam A. The radiologist's view of expandable metallic stents for malignant esophageal obstruction. Gastrointest Endosc Clin N Am. 1999; 9:431–435. PMID: 10388858.
Article
30. Tringali A, Familiari P, Mutignani M, Perri V, Costamagna G. Self-expandable, removable, fully covered metal stents to dilate common bile duct strictures secondary to chronic pancreratitis: preliminary results. Gastrointest Endosc. 2010; 71:AB169–AB170.
31. Moon SH, Kim MH, Park do H, et al. Modified fully covered self-expandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced chronic pancreatitis, with a focus on the safety profile and reducing migration. Gastrointest Endosc. 2010; 72:86–91. PMID: 20493483.
Article
32. Park do H, Lee SS, Lee TH, et al. Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos). Gastrointest Endosc. 2011; 73:64–70. PMID: 21184871.
33. Mahajan A, Ho H, Sauer B, et al. Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video). Gastrointest Endosc. 2009; 70:303–309. PMID: 19523620.
Article
34. Khan I, Smith N, Jones E, Finch DS, Cameron RE. Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part I: materials selection and evaluation. Biomaterials. 2005; 26:621–631. PMID: 15282140.
Article
35. Lee DK. Drug-eluting stent in malignant biliary obstruction. J Hepatobiliary Pancreat Surg. 2009; 16:628–632. PMID: 19554255.
Article
36. Kalinowski M, Alfke H, Kleb B, Dürfeld F, Joachim Wagner H. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions. Invest Radiol. 2002; 37:399–404. PMID: 12068162.
37. Lee DK, Kim HS, Kim KS, et al. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc. 2005; 61:296–301. PMID: 15729251.
Article
38. Lee SS, Shin JH, Han JM, et al. Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model. Gastrointest Endosc. 2009; 69:1140–1147. PMID: 19243763.
Article
39. Suk KT, Kim JW, Kim HS, et al. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointest Endosc. 2007; 66:798–803. PMID: 17905025.
Article
40. Jang SI, Kim JH, You JW, et al. Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study. Dig Dis Sci. 2013; 58:865–871. PMID: 23179148.
Article
41. Moon S, Yang SG, Na K. An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis. Biomaterials. 2011; 32:3603–3610. PMID: 21334742.
Article
42. Guo SR, Wang ZM, Zhang YQ, et al. In vivo evaluation of 5-fluorouracil-containing self-expandable nitinol stent in rabbits: efficiency in long-term local drug delivery. J Pharm Sci. 2010; 99:3009–3018. PMID: 20091819.
Article
43. Jang SI, Kim JH, Kim M, et al. Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane. Endoscopy. 2012; 44:825–831. PMID: 22752887.
Article
44. Chung MJ, Kim H, Kim KS, Park S, Chung JB, Park SW. Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model. J Gastroenterol Hepatol. 2012; 27:261–267. PMID: 21793905.
Article
45. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004; 364:1497–1504. PMID: 15500894.
Article
46. Bergquist H, Johnsson E, Nyman J, et al. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer: results of a prospective safety study. Dis Esophagus. 2012; 25:410–415. PMID: 21899654.
47. Guo JH, Teng GJ, Zhu GY, He SC, Deng G, He J. Self-expandable stent loaded with 125I seeds: feasibility and safety in a rabbit model. Eur J Radiol. 2007; 61:356–361. PMID: 17085003.
Article
48. Guo JH, Teng GJ, Zhu GY, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008; 247:574–581. PMID: 18349316.
49. Liu Y, Liu JL, Cai ZZ, et al. A novel approach for treatment of unresectable extrahepatic bile duct carcinoma: design of radioactive stents and an experimental trial in healthy pigs. Gastrointest Endosc. 2009; 69(3 Pt 1):517–524. PMID: 19231492.
Article
50. Laasch HU, Marriott A, Wilbraham L, Tunnah S, England RE, Martin DF. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology. 2002; 225:359–365. PMID: 12409567.
Article
51. Misra SP, Dwivedi M. Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement. Gastrointest Endosc. 2009; 70:317–321. PMID: 19539920.
Article
52. Homs MY, Wahab PJ, Kuipers EJ, et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc. 2004; 60:695–702. PMID: 15557944.
Article
53. Hu B, Wang TT, Shi ZM, et al. A novel antireflux metal stent for the palliation of biliary malignancies: a pilot feasibility study (with video). Gastrointest Endosc. 2011; 73:143–148. PMID: 20970788.
Article
54. Köcher M, Dlouhy M, Neoral C, et al. Esophageal stent with antireflux valve for tumors involving the cardia: work in progress. J Vasc Interv Radiol. 1998; 9:1007–1010. PMID: 9840050.
Article
55. Davies RP, Kew J, Byrne PD. Treatment of post-stent gastroesophageal reflux by anti-reflux Z-stent. Cardiovasc Intervent Radiol. 2000; 23:487–489. PMID: 11232903.
Article
56. Do YS, Choo SW, Suh SW, et al. Malignant esophagogastric junction obstruction: palliative treatment with an antireflux valve stent. J Vasc Interv Radiol. 2001; 12:647–651. PMID: 11340148.
57. Kim DU, Kwon CI, Kang DH, Ko KH, Hong SP. New antireflux self-expandable metal stent for malignant lower biliary obstruction: in vitro and in vivo preliminary study. Dig Endosc. 2013; 25:60–66. PMID: 23286258.
58. McGrath JP, Browne M, Riordan C, Ravi N, Reynolds JV. Expandable metal stents in the palliation of malignant dysphagia and oesophageal-respiratory fistulae. Ir Med J. 2001; 94:270–272. PMID: 11820518.
59. Schmidt A, Riecken B, Rische S, et al. Wing-shaped plastic stents vs. self-expandable metal stents for palliative drainage of malignant distal biliary obstruction: a randomized multicenter study. Endoscopy. 2015; 47:430–436. PMID: 25590188.
Article
60. de la Serna-Higuera C, Pérez-Miranda M, Gil-Simón P, et al. EUS-guided transenteric gallbladder drainage with a new fistula-forming, lumen-apposing metal stent. Gastrointest Endosc. 2013; 77:303–308. PMID: 23206813.
Article
61. Saito Y, Tanaka T, Andoh A, et al. Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci. 2008; 53:330–333. PMID: 17713855.
Article
62. Vandenplas Y, Hauser B, Devreker T, Urbain D, Reynaert H. A degradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child. Endoscopy. 2009; 41(Suppl 2):E73. PMID: 19319789.
Article
63. Kwon CI, Ko KH, Hahm KB, Kang DH. Functional self-expandable metal stents in biliary obstruction. Clin Endosc. 2013; 46:515–521. PMID: 24143314.
Article
64. Fry SW, Fleischer DE. Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc. 1997; 45:179–182. PMID: 9041006.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr